Abstract
A 64-year-old man diagnosed with advanced malignant peritoneal mesothelioma by laparoscopic biopsy was treated with systemic chemotherapy. The patient underwent first-line chemotherapy with pemetrexed plus cisplatin for 11months, then second-line chemotherapy with gemcitabine plus vinorelbine for 6months, and third-line chemotherapy with CPT-11 for 4months. After third-line chemotherapy failed, he received palliative treatment. Although the tumor continued to grow, and he died 24months after initiation of treatment, chemotherapy prolonged the survival time and improved his quality of life.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
